A research team has identified the impact of stem cell infusion timing on the incidence and severity of acute ...
MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells ...
The 2nd Pediatric Hematology and Oncology Conference will begin on Monday, under the patronage of Health Minister Dr. Ahmad ...
One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules ...
A research team led by Prof. ZHAN Cheng from the University of Science and Technology of China (USTC), and Chief Physician ZHU Xiaoyu from the First Affiliated Hospital of USTC has identified how stem ...
Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered ...
The following is a summary of “BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma,” published in ...
Sion Hospital in Mumbai to expand bone marrow transplant facility after a decade of life-saving work
Sion Hospital, Mumbai’s first civic hospital with a bone marrow transplant unit, plans to expand its pediatric BMT facility ...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a critical therapeutic strategy for treating conditions such as hematological ...
Sponsored content brought to you by In the rapidly advancing field of immuno-oncology research, there has been increasing ...
Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does ...
Monzr M. Al Malki, MD, discussed data for AlloHeme, a blood test used to detect risk of relapse post-transplant in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback